Lundbeck

Lundbeck is a pharmaceutical company that specializes in research, development and commercialization of drugs for psychiatric and neurological disorders. Read more

Deborah Dunsire's photo - President & CEO of Lundbeck

President & CEO

Deborah Dunsire

CEO Approval Rating

85/100

Founded:

1915

Status:

PublicIndependent CompanyNASDAQLUN (CPH)

LUNDBECK TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Merck is seen as one of Lundbeck's top competitors. Merck's headquarters is in Kenilworth, New Jersey, and was founded in 1891. Like Lundbeck, Merck also works within the Pharmaceuticals industry. Merck generates 1,646% of Lundbeck's revenue.

Mylan is one of Lundbeck's top rivals. Mylan was founded in 1961, and its headquarters is in Canonsburg, Pennsylvania. Like Lundbeck, Mylan also works within the Pharmaceuticals field. Mylan has 29,283 more employees than Lundbeck.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is TEVA a competitor of Lundbeck?

Lundbeck Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.9B

Lundbeck's revenue is the ranked 18th among it's top 10 competitors. The top 10 competitors average 19.4B. Over the last three quarters, Lundbeck's revenue has grown by 33.5%. Specifically, in Q4 2020's revenue was $880.3M; in Q3 2020, it was $701.6M; in Q2 2020, it was $659.4M.

Lundbeck Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Alder BioPharmaceuticals, Inc.

Sep 2019

Source »
$1.9B
Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.
Abide Therapeutics, Inc.

May 2019

Source »
$250M
Abide is a biotechnology company that develops and commercializes serine hydrolase inhibitors for the treatment of neurological diseases.
Prexton Therapeutics BV

Mar 2018

Source »
$123.4M
Prexton Therapeutics develops novel therapeutic compounds for the treatment of brain disorders and CNS diseases.

-

NeuronIcon

Jul 2009

Source »
undisclosed
-

-

LifeHealth

Jul 2009

Source »
$147M
-

These are all the companies that Lundbeck has acquired. Lundbeck has acquired 9 companies and its latest acquisition was Alder BioPharmaceuticals, Inc. in Sep 2019. Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.

Lundbeck Funding History

No recent funding data found related to Lundbeck

Lundbeck Investments

No recent investments found related to Lundbeck

These are all the companies that Lundbeck has invested in. Lundbeck has invested 9 companies and its latest investment was Alder BioPharmaceuticals, Inc. in Sep 2019. Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.

Lundbeck News

May 11, 2021MarketScreener

Lundbeck banks on key drugs to offset patent expiration

(marketscreener.com) COPENHAGEN -Danish drugmaker Lundbeck expects a pickup in demand for its main dr... See more »
May 11, 2021News Break

Lundbeck posts first quarter sales slightly above expectations, keeps guidance - News Break

COPENHAGEN (Reuters) - Danish drugmaker Lundbeck on Tuesday posted first-quarter sales slightly above... See more »
May 6, 2021MarketScreener

Lundbeck Earns the Best Place To Work Certification in South Africa

(marketscreener.com) Lundbeck South Africa, an affiliate of the global biopharmaceutical company comm... See more »
March 29, 2021Competition Policy International

expected and valuable clarifications for the future

By: Pablo Ibañez Colomo (Chilling Competition) The Court of Justice has delivered an important set of... See more »
March 28, 2021FiercePharma

Otsuka, Lundbeck get real with CGI in first Abilify Maintena DTC campaign

Otsuka, Lundbeck get real with CGI in first Abilify Maintena DTC campaign bbulik Sun, 03/28/2021 - 19... See more »
March 25, 2021Competition Policy International

Lundbeck Loses EU Pay-For-Delay Against EU Fine

Danish drugmaker Lundbeck on Thursday lost its fight against a 2013 EU antitrust fine imposed for dea... See more »

Lundbeck Blogs

May 20, 2018Lundbeck Blog

Granddad Peter - Evil Perpetrator or Equally Innocent Victim?

Ireland has seen far too many murder-suicides for such a small country - with much discussion and no ... See more »
February 25, 2018Lundbeck Blog

Never Mind The Science Bit - The Latest Antidepressant Research is Out.

Roll up! Roll up! The 'latest' antidepressant research is out - 'Comparative efficacy and acceptabi... See more »
December 26, 2017Lundbeck Blog

Dancing to the Piper's tune..

What's wrong with the above image, you might ask? What harm could possibly be drawn from this innocuo... See more »
November 30, 2017Lundbeck Blog

The Dead Don't Lie - A Message From Beyond

A report published this month by ScotSID (Scottish Suicide Information Database) makes for very inter... See more »
October 19, 2017Lundbeck Blog

Jake's Amendment Fails. And Yet..

The only thing necessary for the triumph of evil is for good men to do nothing - Edmund Burke. I kn... See more »
July 28, 2017Lundbeck Blog

Panorama - A Prescription for Murder.

This week the BBC aired a Panorama documentary titled 'A Prescription for Murder' which has stirred s... See more »
July 21, 2017Lundbeck Blog

Antidepressant Addiction

It always surprises me that while most medics admit that all drugs can have serious adverse effects, ... See more »

Lundbeck Press Releases

October 8, 2020Cision

Lundbeck successfully places its first EUR 500 million Eurobond issue

Valby, Denmark, 8 October 2020 - H. Lundbeck A/S (Lundbeck) has successfully placed its first... See more »
September 17, 2020Cision

Lundbeck presents positive data from the COMPLETE study with vortioxetine

The study, which assessed treatment with vortioxetine for emotional blunting in Major Depressive... See more »
June 9, 2020Cision

Lundbeck plans to refocus and reinvigorate Research & Development

As part of its Expand and Invest to Grow-strategy, Lundbeck plans to make changes to its... See more »
May 12, 2020Business Wire

Patient Groups Rank Lundbeck #1 in Corporate Reputation for 5th Straight Year

DEERFIELD, Ill.--(BUSINESS WIRE)--For the fifth year in a row, our patient-group partners ranked Lund... See more »
March 25, 2020Business Wire

VYEPTI (eptinezumab-jjmr) Demonstrated Significant Positive Impact in Prevention of Chronic Migraine in Adults, Pivotal Phase III Study Published in Neurology Finds

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck announced that findings from the Phase III study PROMISE 2... See more »
August 14, 2019GlobalNewswire

Otsuka America Pharmaceutical, Inc. & Lundbeck Release The Second Edition Trends In Behavioral Health Guide

Gettysburg, Pa, Aug. 14, 2019 (GLOBE NEWSWIRE) -- New guide on the U.S. behavioral health financing a... See more »
May 22, 2019GlobeNewswire

Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants

Valby, Denmark, 22 May 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to incre... See more »

Lundbeck Videos

Social Media

Lundbeck Headquarters

Ottiliavej 9

Valby, Other2500

45-3630-1311

Driving Directions »

Trending Companies

Lundbeck Summary

ABOUT

Overview

Lundbeck is a pharmaceutical company that specializes in research, development and commercialization of drugs for psychiatric and neurological disorders. Lundbeck was founded in 1915. Lundbeck's headquarters is located in Valby, Other, DK 2500. Lundb...

CEO

Lundbeck's President & CEO, Deborah Dunsire, currently has an approval rating of 85%. Lundbeck's primary competitors are Merck, Mylan & Axovant.

Frequently Asked Questions about Lundbeck

  1. When was Lundbeck founded?

    Lundbeck was founded in 1915
  2. Who is Lundbeck's CEO?

    Lundbeck's CEO is Deborah Dunsire
  3. How much revenue does Lundbeck generate?

    Lundbeck generates $2.9B in revenue
  4. How much funding does Lundbeck have?

    Lundbeck has historically raised $0 in funding
  1. Where is Lundbeck's headquarters?

    Lundbeck's headquarters is in Valby Other, DK
  2. How many employees does Lundbeck have?

    Lundbeck has 5,717 employees
  3. What sector does Lundbeck operate in?

    Lundbeck is in Pharmaceuticals, Medical Research & Laboratories
  4. Who are Lundbeck's competitors?

    Lundbeck's top competitors are Merck, Mylan, Axovant